Showing 641 - 660 results of 1,182 for search '"liver disease"', query time: 0.08s Refine Results
  1. 641

    CIHR Canadian HIV Trials Network Co-Infection and Concurrent Diseases Core: Updated Canadian Guidelines for the Treatment of Hepatitis C Infection in HIV-hepatitis C Coinfected Adu... by Mark Hull, Stephen Shafran, Alice Tseng, Pierre Giguère, Marina B Klein, Curtis Cooper

    Published 2014-01-01
    “…Management of HIV-HCV coinfection is more complex due to the accelerated progression of liver disease, the timing and nature of antiretroviral and HCV therapy, mental health and addictions management, socioeconomic obstacles and drug-drug interactions between new HCV direct-acting antiviral therapies and antiretroviral regimens.…”
    Get full text
    Article
  2. 642

    Early Changes in Hepatitis C Virus (HCV) RNA Levels Predict Response to Interferon Treatment in Non-Cirrhotic HCV Patients by Glen Fallows, Kelly Kaita, Gerald Minuk, Faye Penner, Gerry Smart, Magdy Dawood, Barry Rosser

    Published 2000-01-01
    “…The role of hepatitis C virus (HCV) RNA quantification in determining ideal interferon (IFN) treatment of noncirrhotic HCV liver disease is uncertain. The specific aim of this study was to determine whether measurement of baseline HCV RNA or changes in HCV RNA levels ( HCV RNA) early during therapy predict response to IFN in noncirrhotic HCV patients.…”
    Get full text
    Article
  3. 643

    Pregnancy Following Liver Transplantation: Review of Outcomes and Recommendations for Management by Kuljit S Parhar, Paul S Gibson, Carla S Coffin

    Published 2012-01-01
    “…Liver transplantation is considered to be the treatment of choice for end-stage liver disease and its success has led to an increase in the number of female liver transplant recipients who are of childbearing age. …”
    Get full text
    Article
  4. 644

    Characteristics of Hepatitis C Virus Infection in HIV-Infected People by Curtis L Cooper, Andrew D Badley, Jonathan B Angel

    Published 2001-01-01
    “…Co-infected individuals develop histological and clinical features of HCV liver disease more rapidly than HIV-seronegative patients. …”
    Get full text
    Article
  5. 645

    Laparoscopic Sleeve Gastrectomy in a Morbidly Obese Patient with Myasthenia Gravis: A Review of the Management by Megana Ballal, Tracey Straker

    Published 2015-01-01
    “…This report describes the case of a 27-year-old morbidly obese woman with a past medical history significant for myasthenia gravis and fatty liver disease undergoing bariatric surgery. Anesthesia was induced with intravenous agents and maintained with an inhalational and balanced intravenous technique. …”
    Get full text
    Article
  6. 646

    Vibrio vulnificus specie isolation in series blood culture. A case report. by Elio Jesús Núñez Tamayo, Susana Chamero Melgarejo, Julián Viera Yanez, Belkys Rodríguez Llerena, Nancy Ramírez Martínez, Dania Peñaranda Pordomingo, Annia Alvarado Borges

    Published 2004-08-01
    “…This papers contains a report of a case with Vibrio vulnificuls, gram negative micro organism that ferments carbohydrates and that is positive to the oxidase test and halophile in a patient with history of heart and liver disease who was assisted at the Intensive Care Emergency Unit ( ICU )of the ¨Dr. …”
    Get full text
    Article
  7. 647

    Organizing Pneumonia Associated with Pegylated Interferon α and Ribavirin Therapy by Amit Chopra, Creticus Marak, Narendrakumar Alappan, Chang Shim

    Published 2015-01-01
    “…Hepatitis C virus infection is the leading cause of chronic liver disease in the United States of America. Pegylated interferon α and ribavirin combination is the mainstay of treatment. …”
    Get full text
    Article
  8. 648

    Hepatocellular Bile Salt Transport: Lessons from Cholestasis by Michael Trauner, Peter Fickert, Rudolf E Stauber

    Published 2000-01-01
    “…This review summarizes the molecular defects in hepatocellular membrane transporters that are associated with hereditary and acquired forms of cholestatic liver disease.…”
    Get full text
    Article
  9. 649

    Progression of Hepatic Adenoma to Carcinoma in the Setting of Hepatoportal Sclerosis in HIV Patient: Case Report and Review of the Literature by M. I. Montenovo, F. G. Jalikis, M. Yeh, J. D. Reyes

    Published 2016-01-01
    “…This case also highlights the broad differential diagnosis that should always be included in the study of any liver disease in this patient population, including the performance of invasive and aggressive tests to arrive at the final diagnosis.…”
    Get full text
    Article
  10. 650
  11. 651

    CALLY index, but not HALP score, is associated with mortality in cirrhosis patients by Yıldız Günay, Bedel Cihan, Zortuk Ökkeş, Selvi Fatih, Karanci Yusuf

    Published 2025-01-01
    “…Cirrhosis is a chronic liver disease that is characterized by inflammation and fibrosis, as well as liver dysfunction. …”
    Get full text
    Article
  12. 652

    Polycystic Diseases in Visceral Organs by Shakila Abdul-Majeed, Surya M. Nauli

    Published 2011-01-01
    “…Aside from polycystic kidney disease (PKD), however, the roles of cilia in polycystic liver disease (PLD), polycystic pancreas disease (PPD), and polycystic ovarian syndrome (PCOS) are still very vague. …”
    Get full text
    Article
  13. 653

    Differential Expression Profiles of mRNA and Noncoding RNA and Analysis of Competitive Endogenous RNA Regulatory Networks in Nonalcoholic Steatohepatitis by Mengjia Gao, Jingxin Xin, Xiaoling Li, Ling Gao, Shanshan Shao, Meng Zhao

    Published 2022-01-01
    “…Nonalcoholic steatohepatitis (NASH) is a liver disease caused by multiple factors, and there is no approved pharmacotherapy. …”
    Get full text
    Article
  14. 654
  15. 655

    Combination Treatments of Plasma Exchange and Umbilical Cord-Derived Mesenchymal Stem Cell Transplantation for Patients with Hepatitis B Virus-Related Acute-on-Chronic Liver Failur... by Wen-xiong Xu, Hong-liang He, Shun-wen Pan, Yuan-li Chen, Mei-ling Zhang, Shu Zhu, Zhi-liang Gao, Liang Peng, Jian-guo Li

    Published 2019-01-01
    “…The multivariate logistic regression analysis demonstrated that hemoglobin, prothrombin activity, and MELD (model for end-stage liver disease) score were the independent factors associated with the unfavorable outcome (all P<0.05). …”
    Get full text
    Article
  16. 656

    Effect of Daily Fiber Intake Among Cirrhotic Patients With and Without Portosystemic Shunts by Simona Parisse, Sara Carnevale, Elio Damato, Flaminia Ferri, Monica Mischitelli, Mario Corona, Pierleone Lucatelli, Alfredo Cantafora, Adriano De Santis, Domenico Alvaro, Maurizio Muscaritoli, Stefano Ginanni Corradini

    Published 2025-01-01
    “…In CIRs, the presence of PSs was verified by computed tomography, and the model for end-stage liver disease (MELD) score was calculated at enrollment and after 6 mo. …”
    Get full text
    Article
  17. 657
  18. 658

    Alström’s Syndrome, Leber’s Hereditary Optic Neuropathy, or Retinitis Pigmentosa? A Case of Misdiagnosis by Palaiologos Alexopoulos, Chrysanthos Symeonidis, Tryfon Rotsos

    Published 2023-01-01
    “…AS affects metabolism, and symptomatology includes type 2 diabetes mellitus (T2DM), obesity, hypogonadism and gynecomastia in males, progressive bilateral sensorineural hearing loss, cardiomyopathy, nonalcoholic fatty liver disease (NAFLD), cirrhosis, and chronic progressive kidney disease. …”
    Get full text
    Article
  19. 659

    Autoimmune Hepatitis: Clinical Manifestations and Diagnostic Criteria by Ian G Mcfarlane

    Published 2001-01-01
    “…This review (published in 1999) noted that the original descriptive criteria appeared to be quite robust and required only relatively minor modifications to bring them up to date with developments and experience in diagnostic modalities for liver disease in general. Analysis of published data on the application of the original criteria in nearly 1000 patients revealed that the diagnostic scoring system had an overall diagnostic accuracy of 89.8%, with a sensitivity of 98.0%. …”
    Get full text
    Article
  20. 660

    Risk Factors for Hepatitis C Virus Transmission Obscure in Nigerian Patients by Olive Obienu, Sylvester Nwokediuko, Abraham Malu, Olufunmilayo A. Lesi

    Published 2011-01-01
    “…This warrants further studies on the epidemiology of this important cause of liver disease.…”
    Get full text
    Article